Cboe Global Markets Reports Results for Third Quarter 2026

Cboe Global Markets reported Q3 2026 earnings with net revenue of $712.2M, up 18%. Diluted EPS rose 43% to $4.08, and adjusted diluted EPS grew 36% to $3.63. The company raised its 2026 organic net revenue growth target to 'high teens' and lowered adjusted operating expense guidance to $830-$845M.

Original reporting
Published Oct 30, 2026, 11:30 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 30, 2026, 11:33 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Cboe Global Markets Reports Results for Third Quarter 2026 — source image
Decision brief

The 30-second read

$CBOEBullishHigh
01

Why it matters

The earnings beat and guidance raise suggest continued growth in options volume and data services, supporting a bullish outlook for the exchange sector.

02

Market read

Cboe's strong Q3 results and raised guidance are likely to lift its stock and positively influence related exchange and data service stocks.

03

What to watch

Higher operating expenses and a modest decline in futures revenue could temper upside.

Relevance 8/10Novelty 9/10Timing: released today

Background

Cboe Global Markets is a leading U.S. exchange operator; its earnings are closely watched for insight into options and data revenue trends.

Company-level read

Ticker impact

$CBOEBullishHigh confidence
Context

Cboe Global Markets reported Q3 2026 earnings with record EPS, 18% revenue growth and raised FY guidance.

Expected impact

upward pressure as investors price in higher earnings and guidance

Evidence & confidence

EPS beat, revenue beat, and guidance raise are fresh primary data that typically drive a positive move.

Market effects

Derivatives and data services sectors may see broader optimism from Cboe's strong performance.

U.S. equity markets could get a modest boost from the earnings beat.

Limited to U.S. markets; no direct global macro effect.

Counterpoint

If the market has already priced in the beat, the stock could face a short‑term pullback.

Key entities

  • Cboe Global Markets, Inc.

    U.S.-listed exchange operator reporting Q3 2026 results.

Related articles

$CBOEMed

CFTC turns Cboe’s own words against it in stock perpetuals lawsuit

The CFTC allowed stock perpetual futures to proceed, then faced a lawsuit from the Capital Markets Alliance (Cboe, Citadel Securities, Healthy Markets Association). The CFTC's defense uses Cboe's past statements and product designs, arguing inconsistency in classification. The alliance's structure and location are also questioned. The case hinges on whether these products are security futures or swaps.

$CMEMed

Trump administration’s embrace of "perp" futures sets off risk alarms for Wall Street stalwarts

The Trump administration's push for perpetual futures (perps) in the US has raised concerns among traditional exchanges like CME Group and Cboe Global Markets, which argue the products are misclassified as futures and pose new risks. Perps, popular in crypto markets, trade 24/7 and can be highly leveraged. The CFTC approved US-listed crypto perps in May, and last week approved single-stock equity perps, sparking lawsuits from incumbent exchanges.

$CBOEMed

Cboe, Citadel Securities and Healthy Markets Sue CFTC Over Stock Perpetuals

Cboe, Citadel Securities, and Healthy Markets sued the CFTC over its approval of perpetual derivatives tied to individual US stocks, arguing they should be classified as security-based swaps under SEC oversight. A judge questioned the CFTC's authority but denied an emergency halt. The case involves KalshiEX, Bitnomial Exchange, and Coinbase Derivatives, with a preliminary injunction request pending.

$CBOEMed

Cboe and Citadel Securities-backed industry body contests CFTC green light for single-stock perpetual derivatives

The Capital Markets Alliance (CMA), backed by Cboe and Citadel Securities, sued the CFTC over its approval of single-stock perpetual derivatives. The CMA argues these products should fall under SEC jurisdiction and that the CFTC violated the Administrative Procedure Act. The CMA seeks to vacate the approvals, but a judge denied an emergency restraining order, indicating the CMA may succeed in its claim. The CFTC and CMA are set to respond by November 6 and 10, respectively.

$CBOEMed

Cboe and Citadel Securities Are Suing to Overturn the CFTC’s Approval of Stock Perpetual Futures. Could That Slow Hyperliquid?

Cboe Global Markets (CBOE) and Citadel Securities sued to overturn the CFTC's approval of stock perpetual futures, which Hyperliquid (HYPE) lists outside the U.S. The lawsuit aims to classify these contracts as security-based swaps and halt trading. HYPE's token is trading at $86, down 1.3% in 24 hours but up 7.4% in a week. The lawsuit could impact U.S. exchanges like Coinbase (COIN) and Bitnomial, while Hyperliquid's offshore operations may face fewer competitors in the short term.

$CBOELow

Analysis: Cboe, Citadel Securities backed group sues CFTC over stock perpetuals

The Capital Markets Alliance (CMA), backed by Cboe and Citadel Securities, sued the CFTC to halt perpetual futures trading on individual US stocks, arguing they should be classified as security-based swaps. The CFTC approved the contracts, but the CMA claims they should require SEC registration for retail sales. The lawsuit also questions the CFTC's approval process, which automatically approved the products after 45 days without objection.